phase readout
saveNCT06868732: Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC
RECRUITINGupdated 25m ago
community read0 votes
Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd. Phase: PHASE1. Conditions: Advanced Non-small Cell Lung Cancer
view source ↗
comments(0)
5-min edit window · permanent after that